Acute visceral pain relief mediated by A3AR agonists in rats: involvement of N-type voltage-gated calcium channels.


Journal

Pain
ISSN: 1872-6623
Titre abrégé: Pain
Pays: United States
ID NLM: 7508686

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 31 01 2020
accepted: 14 04 2020
pubmed: 8 5 2020
medline: 15 5 2021
entrez: 8 5 2020
Statut: ppublish

Résumé

Pharmacological tools for chronic visceral pain management are still limited and inadequate. A3 adenosine receptor (A3AR) agonists are effective in different models of persistent pain. Recently, their activity has been related to the block of N-type voltage-gated Ca2+ channels (Cav2.2) in dorsal root ganglia (DRG) neurons. The present work aimed to evaluate the efficacy of A3AR agonists in reducing postinflammatory visceral hypersensitivity in both male and female rats. Colitis was induced by the intracolonic instillation of 2,4-dinitrobenzenesulfonic acid (DNBS; 30 mg in 0.25 mL 50% EtOH). Visceral hypersensitivity was assessed by measuring the visceromotor response and the abdominal withdrawal reflex to colorectal distension. The effects of A3AR agonists (MRS5980 and Cl-IB-MECA) were evaluated over time after DNBS injection and compared to that of the selective Cav2.2 blocker PD173212, and the clinically used drug linaclotide. A3AR agonists significantly reduced DNBS-evoked visceral pain both in the postinflammatory (14 and 21 days after DNBS injection) and persistence (28 and 35 days after DNBS) phases. Efficacy was comparable to effects induced by linaclotide. PD173212 fully reduced abdominal hypersensitivity to control values, highlighting the role of Cav2.2. The effects of MRS5980 and Cl-IB-MECA were completely abolished by the selective A3AR antagonist MRS1523. Furthermore, patch-clamp recordings showed that A3AR agonists inhibited Cav2.2 in dorsal root ganglia neurons isolated from either control or DNBS-treated rats. The effect on Ca2+ current was PD173212-sensitive and prevented by MRS1523. A3AR agonists are effective in relieving visceral hypersensitivity induced by DNBS, suggesting a potential therapeutic role against abdominal pain.

Identifiants

pubmed: 32379223
pii: 00006396-202009000-00023
doi: 10.1097/j.pain.0000000000001905
pmc: PMC8272921
mid: NIHMS1716021
doi:

Substances chimiques

Adenosine A3 Receptor Agonists 0
Calcium Channels, N-Type 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2179-2190

Subventions

Organisme : Intramural NIH HHS
ID : Z01 DK031117
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DK031117
Pays : United States

Informations de copyright

Copyright © 2020 International Association for the Study of Pain.

Références

Bioorg Med Chem Lett. 1999 Jul 5;9(13):1813-8
pubmed: 10406647
Neuron. 2017 Dec 20;96(6):1317-1326.e4
pubmed: 29198756
Compr Physiol. 2016 Sep 15;6(4):1609-1633
pubmed: 27783853
Med Res Rev. 2018 Jul;38(4):1031-1072
pubmed: 28682469
Bioorg Med Chem Lett. 1999 Aug 2;9(15):2151-6
pubmed: 10465535
Neurochem Int. 2010 Jan;56(1):35-41
pubmed: 19723551
J Neurophysiol. 1997 Jul;78(1):43-50
pubmed: 9242259
Exp Neurol. 2012 Apr;234(2):362-72
pubmed: 22036747
Anesth Analg. 2005 Nov;101(5):1417-21
pubmed: 16244004
J Pain. 2009 May;10(5):447-85
pubmed: 19411059
Pain. 2018 Jun;159(6):1025-1034
pubmed: 29419652
Brain Behav Immun. 2015 Feb;44:91-9
pubmed: 25220279
Gut. 2017 May;66(5):966-974
pubmed: 28232472
Croat Med J. 2007 Feb;48(1):9-21
pubmed: 17309135
Biol Sex Differ. 2016 Jul 14;7:33
pubmed: 27429736
Biotech Histochem. 2005 Mar-Apr;80(2):79-87
pubmed: 16195173
Anesthesiology. 2007 Nov;107(5):797-806
pubmed: 18073555
J Pharmacol Exp Ther. 2006 Jun;317(3):938-45
pubmed: 16474005
J Vis Exp. 2012 Sep 11;(67):
pubmed: 22990580
J Med Chem. 2018 Jan 11;61(1):305-318
pubmed: 29257884
Drug Discov Today. 2012 Apr;17(7-8):359-66
pubmed: 22033198
Neuron. 1993 Jan;10(1):11-20
pubmed: 7678964
Inflamm Bowel Dis. 2014 Dec;20(12):2433-49
pubmed: 25208108
Br J Pharmacol. 2010 May;160(1):101-15
pubmed: 20331607
J Neurophysiol. 1999 Mar;81(3):1391-403
pubmed: 10085364
J Immunol. 1996 Nov 15;157(10):4634-40
pubmed: 8906843
Brain. 2015 Jan;138(Pt 1):28-35
pubmed: 25414036
Nat Rev Gastroenterol Hepatol. 2014 Oct;11(10):611-27
pubmed: 25001973
Gastroenterology. 2013 Dec;145(6):1334-46.e1-11
pubmed: 23958540
Sci Rep. 2017 Jan 05;7:40214
pubmed: 28054654
Life Sci. 1987 Nov 30;41(22):2455-61
pubmed: 3683084
Dig Dis Sci. 2004 Mar;49(3):469-74
pubmed: 15139501
Life Sci. 1988;43(26):2177-81
pubmed: 2850428
J Pain. 2013 Dec;14(12):1585-600
pubmed: 24135431
Am J Physiol Gastrointest Liver Physiol. 2015 Jun 1;308(11):G885-903
pubmed: 25767262
Therap Adv Gastroenterol. 2012 Sep;5(5):339-57
pubmed: 22973418
Sci Rep. 2015 Mar 12;5:9047
pubmed: 25762375
J Neurosci. 2003 May 1;23(9):3908-15
pubmed: 12736360
J Pharmacol Exp Ther. 1983 Oct;227(1):22-7
pubmed: 6312019
Eur J Cancer. 2013 Jan;49(2):482-91
pubmed: 22770890
Pain. 2019 May;160(5):1103-1118
pubmed: 31008816
Pharmacology. 2008;81(2):144-50
pubmed: 17989503
J Neurochem. 2006 Jul;98(2):566-75
pubmed: 16805847
Brain Res. 1988 May 31;450(1-2):153-69
pubmed: 3401708
J Clin Med. 2017 Nov 03;6(11):
pubmed: 29099770
Am J Respir Crit Care Med. 2011 Feb 15;183(4):522-30
pubmed: 20870754
J Med Chem. 1998 Aug 13;41(17):3186-201
pubmed: 9703464
Br J Pharmacol. 2016 Apr;173(8):1253-67
pubmed: 26804983
Inflamm Bowel Dis. 2006 Jan;12(1):38-46
pubmed: 16374257
Br J Pharmacol. 2010 Oct;161(4):856-71
pubmed: 20860664
J Drugs Dermatol. 2016 Aug 1;15(8):931-8
pubmed: 27537992
J Med Chem. 2014 Dec 11;57(23):9901-14
pubmed: 25422861
Am J Gastroenterol. 2012 Nov;107(11):1702-12
pubmed: 22986437
World J Gastroenterol. 2014 Feb 28;20(8):2091-7
pubmed: 24587682
Nat Rev Dis Primers. 2016 Mar 24;2:16014
pubmed: 27159638
Neurogastroenterol Motil. 2008 Apr;20(4):336-42
pubmed: 18179607
Dig Dis Sci. 2004 Jan;49(1):96-101
pubmed: 14992442
Neuroscience. 2002;114(3):523-7
pubmed: 12220556
Eur J Pharmacol. 1999 Jan 8;364(2-3):193-7
pubmed: 9932723
J Neurosci. 2013 Aug 14;33(33):13425-30
pubmed: 23946399
Exp Neurol. 2014 Nov;261:22-33
pubmed: 24967684
Nutrients. 2019 Dec 20;12(1):
pubmed: 31861862
Neurogastroenterol Motil. 2010 Mar;22(3):312-e84
pubmed: 19706070
Br J Pharmacol. 2006 Mar;147(5):524-32
pubmed: 16415905
Am J Physiol Gastrointest Liver Physiol. 2015 Jul 15;309(2):G87-99
pubmed: 26021808
Am J Gastroenterol. 2012 Oct;107(10):1474-82
pubmed: 22929759
Neuromodulation. 2016 Jul;19(5):522-32
pubmed: 26856969
Gut. 2018 Aug;67(8):1543-1552
pubmed: 29563144
Gastroenterology. 2006 Apr;130(5):1480-91
pubmed: 16678561
J Neurosci. 2009 Apr 1;29(13):4076-88
pubmed: 19339603
Life Sci. 2014 Apr 17;101(1-2):1-9
pubmed: 24530739
Dig Liver Dis. 2009 Dec;41(12):844-9
pubmed: 19716778
J Physiol. 1998 Dec 15;513 ( Pt 3):787-804
pubmed: 9824718
Expert Opin Ther Pat. 2017 Aug;27(8):967
pubmed: 28604241
Pain. 2014 Dec;155(12):2560-2567
pubmed: 25242567
Clin Epidemiol. 2014 Feb 04;6:71-80
pubmed: 24523597
Br J Pharmacol. 2002 Jan;135(1):257-65
pubmed: 11786502
PLoS One. 2015 Apr 17;10(4):e0123810
pubmed: 25885345
Gastroenterology. 2004 Mar;126(3):683-92
pubmed: 14988822
Neurogastroenterol Motil. 2015 May;27(5):646-55
pubmed: 25777251
Physiol Rev. 2018 Jul 1;98(3):1591-1625
pubmed: 29848236
Molecules. 2012 Nov 22;17(12):13712-26
pubmed: 23174891
Neuroscience. 2016 Oct 1;333:311-9
pubmed: 27471194
Pain. 2006 Jul;123(1-2):179-86
pubmed: 16630696
Glia. 2004 May;46(4):410-8
pubmed: 15095371
Neuroscience. 2016 Dec 3;338:1-18
pubmed: 26500181
J Rheumatol. 2007 Jan;34(1):20-6
pubmed: 17216675
Br J Anaesth. 2013 Jul;111(1):52-8
pubmed: 23794645
Lancet Neurol. 2015 Feb;14(2):162-73
pubmed: 25575710
Neuroscience. 2008 Jul 17;154(4):1562-7
pubmed: 18550290
J Rheumatol. 2008 Jan;35(1):41-8
pubmed: 18050382
Br J Pharmacol. 2003 Sep;140(2):305-14
pubmed: 12970092
FASEB J. 2012 May;26(5):1855-65
pubmed: 22345405
Br J Pharmacol. 2008 Oct;155(3):407-16
pubmed: 18574457
Nat Rev Gastroenterol Hepatol. 2016 Sep 26;13(10):613-21
pubmed: 27667579
Curr Neuropharmacol. 2016;14(8):842-856
pubmed: 27009115
Trends Mol Med. 2011 Apr;17(4):188-96
pubmed: 21236731
Curr Opin Support Palliat Care. 2012 Mar;6(1):17-26
pubmed: 22246042
Br J Pharmacol. 2015 Jul;172(13):3189-93
pubmed: 25964986
Gut. 2009 Oct;58(10):1333-41
pubmed: 19324867

Auteurs

Elena Lucarini (E)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Elisabetta Coppi (E)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Laura Micheli (L)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Carmen Parisio (C)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Alessia Vona (A)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Federica Cherchi (F)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Anna M Pugliese (AM)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Felicita Pedata (F)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Paola Failli (P)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Seph Palomino (S)

Department of Pharmacology, University of Arizona, College of Medicine Tucson, Tucson, AZ, United States.

Jared Wahl (J)

Department of Pharmacology, University of Arizona, College of Medicine Tucson, Tucson, AZ, United States.

Tally M Largent-Milnes (TM)

Department of Pharmacology, University of Arizona, College of Medicine Tucson, Tucson, AZ, United States.

Todd W Vanderah (TW)

Department of Pharmacology, University of Arizona, College of Medicine Tucson, Tucson, AZ, United States.

Dilip K Tosh (DK)

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.

Kenneth A Jacobson (KA)

Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.

Daniela Salvemini (D)

Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO, United States.
Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University, St. Louis, MO, United States.

Carla Ghelardini (C)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Lorenzo Di Cesare Mannelli (L)

Department of Neuroscience, Psychology, Drug Research and Child Health-Neurofarba-Division of Pharmacology and Toxicology, Florence, Italy.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH